Defunct Company
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
39
NCT02820350
Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients With Acute Kidney Injury (AKI).
Phase: N/A
Role: Collaborator
Start: Dec 4, 2016
Completion: Mar 31, 2020
NCT03836482
Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD
Start: Sep 30, 2025
Completion: Aug 31, 2027